These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unusual 68 Ga-DOTATATE Uptake in Primary Nodal Hemangioma of Axillary Lymph Node. Sariyildiz Gumusgoz H; Burak Z; Karasah Erkek B Clin Nucl Med; 2022 Sep; 47(9):809-810. PubMed ID: 35353744 [TBL] [Abstract][Full Text] [Related]
3. Differential Detection of Hepatic Metastases on 68 Ga-DOTATATE PET/CT and 177 Lu-DOTATATE SPECT/CT. Zahed H; Beauregard JM; Abikhzer G; Rush C; Probst S Clin Nucl Med; 2023 Jan; 48(1):e12-e15. PubMed ID: 36240803 [TBL] [Abstract][Full Text] [Related]
4. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET/CT uptake by primary site-dependent neuroendocrine tumor metastasis. Kunikowska J; Pawlak D; Kolasa A; Mikołajczak R; Królicki L Clin Nucl Med; 2014 Oct; 39(10):855-61. PubMed ID: 25072928 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and Therapeutic Uptake of Intrathyroid Metastasis of Midgut Neuroendocrine Tumor on 68Ga-DOTANOC PET/CT and 177Lu-DOTATATE Imaging. Vija Racaru L; Sinigaglia M; Fontaine S; DʼAure D; Courbon F; Dierickx L Clin Nucl Med; 2019 Jul; 44(7):e445-e448. PubMed ID: 31021912 [TBL] [Abstract][Full Text] [Related]
6. Synchronous Endometrial Cancer Detected on 68 Ga-DOTATATE PET/CT. Mohammadinejad P; Kim A; Koshevarova V; Murphy M; Shagun F; Bhargava P Clin Nucl Med; 2024 Jan; 49(1):96-97. PubMed ID: 37883216 [TBL] [Abstract][Full Text] [Related]
7. 177 Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor. Parghane RV; Basu S Clin Nucl Med; 2022 Oct; 47(10):874-875. PubMed ID: 35353741 [TBL] [Abstract][Full Text] [Related]
8. A prospective randomized, double-blind study to evaluate the diagnostic efficacy of Zhu W; Jia R; Yang Q; Cheng Y; Zhao H; Bai C; Xu J; Yao S; Huo L Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1613-1622. PubMed ID: 34874478 [TBL] [Abstract][Full Text] [Related]
9. Discordance Between Histopathologic Grading and Dual-Tracer PET/CT Findings in Metastatic NETs and Outcome of Adnan A; Basu S J Nucl Med Technol; 2022 Sep; 50(3):248-255. PubMed ID: 34876476 [TBL] [Abstract][Full Text] [Related]
10. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with Sampathirao N; Basu S J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019 [TBL] [Abstract][Full Text] [Related]
11. Bone Metastasis of Glomus Caroticum Demonstrated on 68 Ga-DOTATATE PET/CT. Kesim S; Sen F; Filizoglu N; Ozguven S; Erdil TY Clin Nucl Med; 2022 Nov; 47(11):e706-e707. PubMed ID: 35867988 [TBL] [Abstract][Full Text] [Related]
12. Differences in tumor-to-normal organ SUV ratios measured with 68 Ga-DOTATATE PET compared with 177 Lu-DOTATATE SPECT in patients with neuroendocrine tumors. Wong KK; Frey KA; Niedbala J; Kaza RK; Worden FP; Fitzpatrick KJ; Dewaraja YK Nucl Med Commun; 2022 Aug; 43(8):892-900. PubMed ID: 35703269 [TBL] [Abstract][Full Text] [Related]
13. Radioiodine Uptake in Incidentally Detected Neuroendocrine Tumor: Correlative Imaging With FDG PET/CT and 68 Ga-DOTATATE PET/CT. Hod N; Lantsberg S; Levin D Clin Nucl Med; 2022 Oct; 47(10):e643-e646. PubMed ID: 35485856 [TBL] [Abstract][Full Text] [Related]
14. Combined Quantification of Lee H; Nakamoto R; Moore SE; Pantel AR; Eads JR; Aparici CM; Pryma DA Acad Radiol; 2022 Sep; 29(9):1308-1316. PubMed ID: 34836776 [TBL] [Abstract][Full Text] [Related]
15. Somatostatin receptor imaging in non-(131)I-avid metastatic differentiated thyroid carcinoma for determining the feasibility of peptide receptor radionuclide therapy with (177)Lu-DOTATATE: low fraction of patients suitable for peptide receptor radionuclide therapy and evidence of chromogranin A level-positive neuroendocrine differentiation. Jois B; Asopa R; Basu S Clin Nucl Med; 2014 Jun; 39(6):505-10. PubMed ID: 24662668 [TBL] [Abstract][Full Text] [Related]
16. Concomitant Pancreatitis and Pancreatic Neuroendocrine Tumor on MRI and 68 Ga-DOTATATE PET/CT. Wang J; Kuker R Clin Nucl Med; 2024 Sep; 49(9):868-872. PubMed ID: 38758529 [TBL] [Abstract][Full Text] [Related]
18. Unusual Increased Blood Pool Activity on 68Ga-DOTATATE PET/CT in a Patient With Metastatic Neuroendocrine Disease. Sharma A; Navaz AJ; Pandey MK; Parent EE Clin Nucl Med; 2022 Feb; 47(2):137-139. PubMed ID: 34690295 [TBL] [Abstract][Full Text] [Related]
19. Head-to-Head Comparison of Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731 [No Abstract] [Full Text] [Related]
20. Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors. Crown A; Rocha FG; Raghu P; Lin B; Funk G; Alseidi A; Hubka M; Rosales J; Lee M; Kennecke H J Surg Oncol; 2020 Mar; 121(3):480-485. PubMed ID: 31853990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]